Switch to
More onapp

Ishita Drugs and Industries Ltd

ISHITADR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹16 cr, stock is ranked 3,278
High RiskStock is 4.15x as volatile as Nifty
56.500.05 (-0.09%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹16 cr, stock is ranked 3,278
High RiskStock is 4.15x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
20.88
PB RatioPB Ratio
1.97
Dividend YieldDiv. Yield
Sector PESector PE
35.84
Sector PBSector PB
4.35
Sector Div YldSctr Div Yld
0.89%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ishita Drugs and Industries Limited is an India-based manufacturer of various active pharma ingredients (APIs) (bulk actives and their salts), drug intermediates, excipients and fine chemicals. The Company's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, Indole 2 Carboxylic Acid, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, methyl iodide. It also provides fISHITA DRUGS AND INDUSTRIES LIMITED

Financial TrendFinancial statements 

20192020202120229.2514.9914.2614.200.340.540.830.81
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Hmm, looks like data is unavailable here. Please come back after some time
See all events